LakeShore Biopharma Co. L... (LSB)
2.75
0.13 (4.96%)
At close: Jan 28, 2025, 2:54 PM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY24 | FY23 | FY22 | FY21 |
| Cash & Equivalents | 246.35M | 370.11M | 885.20K | 390.46M |
| Short-Term Investments | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | 200.01M | -345.21M |
| Other Long-Term Assets | 34.36M | 20.92M | -648.76M | 91.37K |
| Receivables | 447.15M | 463.05M | 308.56M | 248.12M |
| Inventory | 203.42M | 185.38M | 166.51M | 81.44M |
| Other Current Assets | 6.24M | 12.29M | 18.64M | 13.19M |
| Total Current Assets | 903.17M | 1.04B | 1.03M | 733.20M |
| Property-Plant & Equipment | 480.62M | 582.89M | 565.00M | 253.45M |
| Goodwill & Intangibles | 71.25M | 78.06M | 80.72M | 83.78M |
| Total Long-Term Assets | 609.86M | 683.77M | 200.01M | 91.37K |
| Total Assets | 1.51B | 1.72B | 201.03M | 91.37K |
| Account Payables | 67.77M | 80.44M | 30.81M | 16.38M |
| Deferred Revenue | 2.02M | 2.30M | 2.30M | 2.12M |
| Short-Term Debt | 323.70M | 198.49M | 116.06M | 3.79M |
| Other Current Liabilities | 405.73M | 377.16M | -150.19M | 321.13M |
| Total Current Liabilities | 802.23M | 658.76M | 142.63K | 70.01K |
| Long-Term Debt | 100.77M | 300.14M | 264.53M | 14.65M |
| Other Long-Term Liabilities | 4.55M | 8.79M | -274.38M | 1.29B |
| Total Long-Term Liabilities | 125.60M | 332.54M | 20.21M | 1.33B |
| Total Liabilities | 927.82M | 991.30M | 20.35M | 70.01K |
| Total Debt | 424.46M | 498.63M | 380.59M | 5.01K |
| Common Stock | 26.11K | 12.30K | 575.00 | 575.00 |
| Retained Earnings | -2.31B | -1.87B | -19.32M | -3.64K |
| Comprehensive Income | -58.18M | -54.41M | 83.09M | 44.22M |
| Shareholders Equity | 585.21M | 728.45M | 180.68M | 21.36K |
| Total Investments | n/a | n/a | 200.01M | -345.21M |